11-2159830-T-G

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_000207.3(INS):​c.*22A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.71 in 1,607,734 control chromosomes in the GnomAD database, including 415,760 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.61 ( 32006 hom., cov: 33)
Exomes 𝑓: 0.72 ( 383754 hom. )

Consequence

INS
NM_000207.3 3_prime_UTR

Scores

13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:10

Conservation

PhyloP100: 1.05
Variant links:
Genes affected
INS (HGNC:6081): (insulin) This gene encodes insulin, a peptide hormone that plays a vital role in the regulation of carbohydrate and lipid metabolism. After removal of the precursor signal peptide, proinsulin is post-translationally cleaved into three peptides: the B chain and A chain peptides, which are covalently linked via two disulfide bonds to form insulin, and C-peptide. Binding of insulin to the insulin receptor (INSR) stimulates glucose uptake. A multitude of mutant alleles with phenotypic effects have been identified, including insulin-dependent diabetes mellitus, permanent neonatal diabetes diabetes mellitus, maturity-onset diabetes of the young type 10 and hyperproinsulinemia. There is a read-through gene, INS-IGF2, which overlaps with this gene at the 5' region and with the IGF2 gene at the 3' region. [provided by RefSeq, May 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.279031E-7).
BP6
Variant 11-2159830-T-G is Benign according to our data. Variant chr11-2159830-T-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 304051.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=10}. Variant chr11-2159830-T-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.927 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
INSNM_000207.3 linkuse as main transcriptc.*22A>C 3_prime_UTR_variant 3/3 ENST00000381330.5
INS-IGF2NR_003512.4 linkuse as main transcriptn.246+955A>C intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
INSENST00000381330.5 linkuse as main transcriptc.*22A>C 3_prime_UTR_variant 3/31 NM_000207.3 P1P01308-1

Frequencies

GnomAD3 genomes
AF:
0.610
AC:
92705
AN:
151854
Hom.:
31998
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.260
Gnomad AMI
AF:
0.662
Gnomad AMR
AF:
0.725
Gnomad ASJ
AF:
0.710
Gnomad EAS
AF:
0.949
Gnomad SAS
AF:
0.831
Gnomad FIN
AF:
0.793
Gnomad MID
AF:
0.793
Gnomad NFE
AF:
0.719
Gnomad OTH
AF:
0.671
GnomAD3 exomes
AF:
0.733
AC:
176653
AN:
240868
Hom.:
67320
AF XY:
0.744
AC XY:
97323
AN XY:
130744
show subpopulations
Gnomad AFR exome
AF:
0.242
Gnomad AMR exome
AF:
0.768
Gnomad ASJ exome
AF:
0.701
Gnomad EAS exome
AF:
0.953
Gnomad SAS exome
AF:
0.833
Gnomad FIN exome
AF:
0.797
Gnomad NFE exome
AF:
0.719
Gnomad OTH exome
AF:
0.736
GnomAD4 exome
AF:
0.720
AC:
1048832
AN:
1455762
Hom.:
383754
Cov.:
40
AF XY:
0.725
AC XY:
524628
AN XY:
723788
show subpopulations
Gnomad4 AFR exome
AF:
0.241
Gnomad4 AMR exome
AF:
0.762
Gnomad4 ASJ exome
AF:
0.705
Gnomad4 EAS exome
AF:
0.958
Gnomad4 SAS exome
AF:
0.827
Gnomad4 FIN exome
AF:
0.793
Gnomad4 NFE exome
AF:
0.713
Gnomad4 OTH exome
AF:
0.716
GnomAD4 genome
AF:
0.610
AC:
92730
AN:
151972
Hom.:
32006
Cov.:
33
AF XY:
0.623
AC XY:
46299
AN XY:
74286
show subpopulations
Gnomad4 AFR
AF:
0.260
Gnomad4 AMR
AF:
0.725
Gnomad4 ASJ
AF:
0.710
Gnomad4 EAS
AF:
0.949
Gnomad4 SAS
AF:
0.831
Gnomad4 FIN
AF:
0.793
Gnomad4 NFE
AF:
0.719
Gnomad4 OTH
AF:
0.675
Alfa
AF:
0.665
Hom.:
16293
Bravo
AF:
0.587
TwinsUK
AF:
0.714
AC:
2648
ALSPAC
AF:
0.697
AC:
2688
ESP6500AA
AF:
0.269
AC:
1174
ESP6500EA
AF:
0.690
AC:
5919
ExAC
AF:
0.716
AC:
85906
Asia WGS
AF:
0.842
AC:
2928
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:10
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 31, 2019- -
Maturity-onset diabetes of the young type 10 Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Diabetes mellitus type 1 Uncertain:1
Uncertain significance, criteria provided, single submitterresearchClinical Genomics, Uppaluri K&H Personalized Medicine Clinic-Potent mutations in this gene can cause early onset diabetes mellitus which is insulin dependent. May have poor response to sulfonylureas, as potent mutations in INS gene can cause beta cell destruction. rs3842753 variant, could be a contributing factor to the increased risk of T1D development, as it might increase insulin production. However more evidence are required to ascertain the role of this particular variant rs3842753 in Type 1 diabetes mellitus . -
Diabetes mellitus, permanent neonatal 4 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
Transient Neonatal Diabetes, Dominant/Recessive Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Hyperproinsulinemia Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
Type 1 diabetes mellitus 2 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
Maturity onset diabetes mellitus in young Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Autosomal recessive DOPA responsive dystonia Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.12
CADD
Benign
0.70
DANN
Benign
0.45
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.00072
N
LIST_S2
Benign
0.15
T
MetaRNN
Benign
8.3e-7
T
MetaSVM
Benign
-0.89
T
MutationTaster
Benign
1.0
P;P;P;P;P
PROVEAN
Benign
0.19
N
REVEL
Benign
0.16
Sift
Benign
0.23
T
ClinPred
0.0091
T
GERP RS
-3.8

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3842753; hg19: chr11-2181060; API